Try our Advanced Search for more refined results
November 02, 2011
Cephalon Inc. et al v. Breckenridge Pharmaceutical Inc. et al
Case Number:
1:11-cv-01070
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
November 02, 2011
Cephalon Targets Breckenridge Over Nuvigil Patent
Cephalon Inc. accused Breckenridge Pharmaceutical Inc. on Wednesday of infringing a patent for Nuvigil in its latest Delaware federal court attempt to keep generic-drug makers from selling versions of the narcolepsy drug before the patent expires.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login